Invesco
NBP

Invesco’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Invesco’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
62,885
+34,724
+123% +$70.8K ﹤0.01% 3705
2026
Q1 		$69.3K Buy
28,161
+7,758
+38% +$26K ﹤0.01% 3665
2025
Q4 		$81.2K Buy
+20,403
New +$90.3K ﹤0.01% 3658
2024
Q3 		– Sell
-57,933
Closed -$96.7K – 3811
2024
Q2 		$96.7K Sell
57,933
-27,211
-32% -$48.6K ﹤0.01% 3757
2024
Q1 		$158K Buy
85,144
+65,381
+331% +$120K ﹤0.01% 3690
2023
Q4 		$37.5K Sell
19,763
-64,399
-77% -$96.2K ﹤0.01% 3773
2023
Q3 		$111K Buy
84,162
+9,225
+12% +$20.3K ﹤0.01% 3703
2023
Q2 		$224K Sell
74,937
-12,085
-14% -$38.8K ﹤0.01% 3582
2023
Q1 		$301K Buy
87,022
+12,077
+16% +$58.5K ﹤0.01% 3501
2022
Q4 		$313K Buy
74,945
+117
+0.2% +$443 ﹤0.01% 3494
2022
Q3 		$300K Sell
74,828
-2
-0% -$15 ﹤0.01% 3512
2022
Q2 		$846K Buy
74,830
+7,219
+11% +$86.5K ﹤0.01% 3061
2022
Q1 		$1.1M Buy
67,611
+25,829
+62% +$662K ﹤0.01% 3030
2021
Q4 		$1.98M Buy
41,782
+6,342
+18% +$381K ﹤0.01% 2799
2021
Q3 		$2.57M Buy
35,440
+11,486
+48% +$831K ﹤0.01% 2700
2021
Q2 		$2.01M Buy
23,954
+7,981
+50% +$527K ﹤0.01% 2839
2021
Q1 		$774K Buy
15,973
+2,376
+17% +$129K ﹤0.01% 3155
2020
Q4 		$641K Buy
13,597
+6,365
+88% +$251K ﹤0.01% 3115
2020
Q3 		$340K Buy
7,232
+54
+0.8% +$1.78K ﹤0.01% 3273
2020
Q2 		$215K Buy
+7,178
New +$148K ﹤0.01% 3456

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco's NBP Position: Q2 2026 in Review

Invesco increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 123% in Q2 2026, buying an estimated $70.8K and bringing the position to 62,885 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3705.

Invesco first reported a position in NBP in Q2 2020 and has held it in 20 quarters since. The position peaked at $2.57M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Invesco held 62,885 shares of NovaBridge Biosciences American Depositary Shares worth $123K as of Q2 2026.
  • Invesco bought 34,724 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $70.8K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3705 holding.
  • Invesco first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 20 quarters since.
  • Invesco's NovaBridge Biosciences American Depositary Shares position peaked at $2.57M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.